Osaic Holdings’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History

Osaic Holdings’s Portfolio GRNA Stock Details GRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-15,400	Closed	-$4.59K	–	7676
2023 Q2	$4.59K	Hold	15,400	–	–	﹤0.01%	6353
2023 Q1	$6.66K	Hold	15,400	–	–	﹤0.01%	6201
2022 Q4	$18K	Hold	15,400	–	–	﹤0.01%	5656
2022 Q3	$36K	Buy	15,400 +10,400	+208%	+$27.2K	﹤0.01%	5161
2022 Q2	$11K	Buy	+5,000	New	+$34.7K	﹤0.01%	6057

Osaic Holdings's GRNA Position: Q3 2023 in Review

Osaic Holdings sold out of GreenLight Biosciences Holdings, PBC Common Stock (GRNA) in Q3 2023, closing a stake of 15,400 shares — an estimated $4.59K sold.

Osaic Holdings first reported a position in GRNA in Q2 2022 and held it in 5 quarters. The position peaked at $36K in Q3 2022. 0 funds tracked by Wall St. Rank hold GRNA as of Q3 2023.

Osaic Holdings reported no remaining GreenLight Biosciences Holdings, PBC Common Stock position as of Q3 2023 after selling out during the quarter.
Osaic Holdings sold 15,400 GreenLight Biosciences Holdings, PBC Common Stock shares in Q3 2023, an estimated $4.59K.
Osaic Holdings first reported a position in GreenLight Biosciences Holdings, PBC Common Stock in Q2 2022 and held it in 5 quarters.
Osaic Holdings's GreenLight Biosciences Holdings, PBC Common Stock position peaked at $36K in Q3 2022.
0 funds tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Common Stock as of Q3 2023.

Based on Osaic Holdings's 13F filing for Q3 2023, filed 13 Nov 2023.